GDRX · CIK 0001809519 · operating
# GoodRx Holdings, Inc.
GoodRx operates a digital platform enabling U.S. consumers to compare prescription drug prices across pharmacies and access negotiated pricing. The company's core offering provides price transparency tools that allow consumers to identify lower-cost alternatives and generate discount codes or coupons at participating pharmacies. Beyond price comparison, GoodRx has expanded into adjacent healthcare services, including GoodRx Care, a telehealth platform offering virtual consultations, and pet health products for dogs, cats, and other animals.
The company generates revenue through multiple streams. Its primary business involves partnerships with pharmacy benefit managers who utilize GoodRx's platform to manage formularies and prescription transactions. The company also derives revenue from subscription offerings and solutions provided to pharmaceutical manufacturers. GoodRx Care contributes telehealth service revenue, while its pet health division represents a supplementary business segment.
Based in Santa Monica, California, GoodRx was founded in 2011 and operates primarily within the United States market. The company serves a broad consumer base seeking prescription cost reduction alongside institutional clients in pharmacy and pharma sectors. The platform's reach extends across the U.S. pharmacy network, enabling price comparisons and discounts at major chains and independent pharmacies.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $0.09 | $0.09 | +125.0% | |
| 2024 | $0.04 | $0.04 | +300.0% | |
| 2023 | $-0.02 | $-0.02 | +75.0% | |
| 2022 | $-0.08 | $-0.08 | -33.3% | |
| 2021 | $-0.06 | $-0.06 | +94.4% | |
| 2020 | $-1.07 | $-1.07 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001809519-26-000031 | SEC ↗ |
| 2024-12-31 | 2025-02-27 | 0001809519-25-000040 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0001809519-24-000032 | SEC ↗ |
| 2022-12-31 | 2023-03-01 | 0000950170-23-005262 | SEC ↗ |
| 2021-12-31 | 2022-03-01 | 0000950170-22-002348 | SEC ↗ |
| 2020-12-31 | 2021-03-12 | 0001564590-21-012614 | SEC ↗ |